DDA / DIA protein ID & quant
Peptide and protein identification and quantification from data-dependent or data-independent acquisition, with FDR control.
From raw mass spectra to proteins, modifications, and 3D structure. We analyse DDA and DIA proteomics—identifying and quantifying proteins and PTMs—and run structural work from AlphaFold prediction to docking and dynamics, handing back tables, models, and figures documented for publication and review.
Proteomics turns raw mass spectra into a quantified picture of the proteins in a sample—which are present, in what amounts, and how they are modified. Structural bioinformatics takes it further, predicting and analysing the 3D shapes those proteins fold into and how they bind. The hard part is rarely running a single tool; it is choosing search and quantification strategies matched to your acquisition, handling missing values and PTM localisation correctly, and documenting every decision so the result survives peer review.
We build and run that workflow for you. Whether you have a DIA proteomics cohort to quantify, a phosphoproteomics experiment to localise, or a protein whose structure and binding you want to model, we apply established, peer-reviewed tools—never opaque in-house black boxes—and return results with the tool versions and parameters recorded for full reproducibility.
One service spanning proteins end to end—from raw mass spectra and quantification to modifications, predicted structures, and binding.
Peptide and protein identification and quantification from data-dependent or data-independent acquisition, with FDR control.
LFQ, TMT/iTRAQ, and SILAC quantification with normalization, batch handling, and match-between-runs where appropriate.
Modification-focused searches with site localisation for phospho, ubiquitin, acetyl, and glyco, plus differential-modification testing.
Rigorous differential-abundance testing across conditions with imputation, mixed models, and multiple-testing control.
Monomer and complex structure prediction with confidence metrics (pLDDT, PAE) for proteins with or without known templates.
Ligand and protein-protein docking to predict binding poses and rank interactions for mechanism and lead exploration.
MD simulations to assess stability, conformational change, and interactions, with free-energy estimates by MM/PBSA.
Structure superposition, similarity search, binding-site and interface analysis, and comparison against known folds.
A transparent, best-practice sequence—each step chosen for your data and question and documented in the final report. Nothing is a black box.
Steps are adapted to your study: DDA vs. DIA, label-free vs. TMT, quantification only vs. structure and docking. We confirm the plan with you before any compute begins.
Instrument-file QC, conversion to open formats where needed, and run-level quality checks before searching.
Tools: ThermoRawFileParser · mzML · RawTools
Database search against your proteome with FDR control—DDA, DIA (library-based or library-free), or both combined.
Tools: DIA-NN · MSFragger · MaxQuant · Percolator
Label-free, isobaric (TMT), or DIA quantification with normalization, roll-up, and missing-value handling.
Tools: IonQuant · TMT · DIA-NN
Rigorous testing across conditions, PTM-site analysis where relevant, and enrichment to interpret the hits.
Tools: MSstats · limma · Perseus
Predict monomer or complex structures, assess confidence, and prepare models for downstream analysis.
Tools: AlphaFold3 · ColabFold · ESMFold
Dock ligands or partners, run molecular-dynamics simulations, and analyse binding sites and interfaces.
Tools: AutoDock Vina · GROMACS · Foldseek
Quant tables, structure models, publication-quality figures, a QC report, and reproducible methods with every tool version.
Tools: PyMOL · ggplot2 · versioned methods manifest
We select from the field's standard toolkit rather than forcing every dataset through one pipeline. A representative set of what we work with:
Identifications and models are only as good as the references behind them. We build on the community's authoritative, versioned resources.
There is no single best acquisition—only the right one for your question and scale. A quick orientation; we will help you decide.
| Dimension | DDA | DIA | Targeted (PRM/SRM) |
|---|---|---|---|
| Acquisition | Selects top ions for fragmentation | Fragments all ions in m/z windows | Monitors a predefined peptide list |
| Quantification | Good; some run-to-run variability | Consistent across many samples | Most precise for chosen targets |
| Missing values | More, in large cohorts | Fewer; reproducible matrices | Minimal for target set |
| Scope | Discovery; strong for PTMs | Deep, large-scale quantification | A focused panel of proteins |
| Best suited to | Exploratory & modification studies | Cohorts & biomarker discovery | Validation & assays |
Not just a protein list dropped in a folder—every output you need to interpret, publish, and reproduce the work.
Every pipeline follows documented best practices—controlled false-discovery rates, careful missing-value handling, and honest reporting of quantification confidence—so a differential hit is real rather than an imputation artifact. For predicted structures we report confidence metrics (pLDDT, PAE) and never present a model as if it were an experimental structure. Each run records its tool versions, parameters, and reference builds.
The practical payoff: your methods section writes itself, a reviewer can re-run the analysis, and a result from today can be reproduced a year from now. We will also tell you honestly when a design or sample size won't support the conclusion you're after.
What researchers and project leads most often ask before starting a proteomics or structural project.
Tell us your organism, data type, and question—we'll scope it honestly, including if a different design would serve you better.